Global Patent Index - EP 1093373 A4

EP 1093373 A4 20050413 - OLIGONUCLEOTIDE INHIBITORS OF bcl-xL

Title (en)

OLIGONUCLEOTIDE INHIBITORS OF bcl-xL

Title (de)

OLIGONUKLEOTIDE INHIBITOREN DES bcl-xl

Title (fr)

OLIGONUCLEOTIDES INHIBITEURS DE bcl-xL

Publication

EP 1093373 A4 20050413 (EN)

Application

EP 99933713 A 19990702

Priority

  • US 9915250 W 19990702
  • US 10961498 A 19980702

Abstract (en)

[origin: CA2336384A1] Published without an abstract

IPC 1-7

A61K 31/70; C07H 21/00

IPC 8 full level

C12N 15/09 (2006.01); A61K 9/127 (2006.01); A61K 9/51 (2006.01); A61K 31/711 (2006.01); A61K 31/712 (2006.01); A61K 31/7125 (2006.01); A61K 47/42 (2006.01); A61K 47/48 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C07H 19/06 (2006.01); C07H 19/12 (2006.01); C07H 19/16 (2006.01); C07H 21/00 (2006.01)

CPC (source: EP US)

A61P 35/00 (2017.12 - EP); C07H 19/06 (2013.01 - EP US); C07H 19/12 (2013.01 - EP US); C07H 19/16 (2013.01 - EP US); C07H 21/00 (2013.01 - EP US)

Citation (search report)

  • [XP] US 5776905 A 19980707 - GIBBONS GARY H [US], et al
  • [A] US 5583034 A 19961210 - GREEN DOUGLAS R [US], et al
  • [A] WO 9508350 A1 19950330 - REED JOHN C [US]
  • [X] POLLMAN M J ET AL: "Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease", NATURE MEDICINE, NATURE PUBLISHING, CO, US, vol. 4, no. 2, February 1998 (1998-02-01), pages 222 - 227, XP002158744, ISSN: 1078-8956
  • [X] AMARANTE-MENDES G P ET AL: "BCL-2-INDEPENDENT BCR-ABL-MEDIATED RESISTANCE TO APOPTOSIS: PROTECTION IS CORRELATED WITH UP REGULATION OF BCL-XL", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 16, 19 March 1998 (1998-03-19), pages 1383 - 1390, XP002923488, ISSN: 0950-9232
  • [A] LUEDTKE G H ET AL: "Antisense oligonucleotides targeting sequences shared by the Bcl-2 and Bcl-xL efficiently downregulate expression of both rpoteins and induce apoptosis of lung cancer cells", PROCEEDINGS OF THE 88TH. ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. SAN DIEGO, APR. 12 - 16, 1997, PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, PHILADELPHIA, AACR, US, vol. VOL.38, 1997, pages 170, XP002080870
  • [A] LEECH G H ET AL: "ANTISENSE OLIGODEOXYNUCLEOTIDES DESIGNED TO DOWNREGULATE THE EXPRESSION OF BCL-XL AND OF BCL-2 AND BCL-XL SIMULTANEOUSLY, RESTORE THE APOPTOTIC RESPONSE OF LUNG CANCER CELL LINES", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, vol. 39, March 1998 (1998-03-01), pages 417, XP000960954, ISSN: 0197-016X
  • [A] LUEDKE G H ET AL: "ANTISENSE OLIGONUCLEOTIDES TARGETING SEQUENCES SHARED BY THE BCL-2 AND THE BCL-XL MRNA EFFICIENTLY DOWNREGULATE EXPRESSION OF BOTH PROTEINS AND INDUCE APOPTOSIS OF LUNG CANCER CELLS", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, no. 38, 1997, pages A1140, XP001084169, ISSN: 0197-016X
  • [AP] CROOKE S T: "BASIC PRINCIPLES OF ANTISENSE THERAPEUTICS", ANTISENSE RESEARCH AND APPLICATIONS, CRC PRESS, GB, 1998, pages 1 - 50, XP000900999

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 0001393 A2 20000113; WO 0001393 A8 20070830; AU 4971199 A 20000124; CA 2336384 A1 20000113; EP 1093373 A1 20010425; EP 1093373 A4 20050413; JP 2002519048 A 20020702; US 2002098231 A1 20020725; US 2003017196 A1 20030123; US 7074769 B2 20060711

DOCDB simple family (application)

US 9915250 W 19990702; AU 4971199 A 19990702; CA 2336384 A 19990702; EP 99933713 A 19990702; JP 2000557839 A 19990702; US 75316901 A 20010102; US 83264801 A 20010411